$AHR
American Healthcare REIT, Inc. Stock $ahr

$ahr Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000163297018000078 Filed on May 11, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$17.84M	$4.052M
YoY Change	340.33%
Cost Of Revenue	$2.351M
YoY Change
Gross Profit	$15.49M
YoY Change
Gross Profit Margin	86.82%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.195M	$1.711M
YoY Change	320.51%
% of Gross Profit	46.45%
Operating Expenses
YoY Change
Operating Profit		$333.0K
YoY Change		-322.0%
Interest Expense	$1.084M	$418.0K
YoY Change	159.33%
% of Operating Profit		125.53%
Other Income/Expense, Net	$1.084M	$418.0K
YoY Change	159.33%
Pretax Income	-$2.236M
YoY Change
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.169M	-$85.00K
YoY Change	2451.76%	-43.33%
Net Earnings / Revenue	-12.16%	-2.1%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$9.158M	$2.059M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$43.92M	$23.16M
YoY Change	89.64%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$503.6M	$218.0M
YoY Change	131.05%	50830.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$107.3M	$58.90M
YoY Change	82.13%	17021.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.34M	-$9.607M
YoY Change	236.6%	6304.67%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity	$503.6M	$218.0M
YoY Change	131.05%	50830.84%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$2.169M	-$85.00K
YoY Change	2451.76%	-43.33%
Depreciation, Depletion And Amortization	$7.195M	$1.711M
YoY Change	320.51%
Cash From Operating Activities	$4.692M	$1.390M
YoY Change	237.55%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$25.49M	-$75.55M
YoY Change	-66.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$51.70M	-$76.13M
YoY Change	-32.09%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$22.87M	$73.99M
YoY Change	-69.08%
NET CHANGE
Cash From Operating Activities	$4.692M	$1.390M
Cash From Investing Activities	-$25.49M	-$75.55M
Cash From Financing Activities	$22.87M	$73.99M
Net Change In Cash	$2.071M	-$178.0K
YoY Change	-1263.48%
FREE CASH FLOW
Cash From Operating Activities	$4.692M	$1.390M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001632970
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2015-01-23
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	Griffin-American Healthcare REIT IV, Inc.
CY2018Q1	dei	Trading Symbol TradingSymbol	gahr4
CY2017Q1	gahr	Accrued Contingent Advisor Payment AccruedContingentAdvisorPayment	7456000	USD
CY2018Q1	gahr	Accrued Contingent Advisor Payment AccruedContingentAdvisorPayment	7760000	USD
CY2017Q1	gahr	Accruedstockholderservicingfee Accruedstockholderservicingfee	6540000	USD
CY2018Q1	gahr	Accruedstockholderservicingfee Accruedstockholderservicingfee	13423000	USD
CY2017Q4	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	9000	USD
CY2018Q1	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	17000	USD
	gahr	Acquisition Aggregated Cost Of Acquired Properties Purchase Price AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePrice	488740000	USD
CY2017Q1	gahr	Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests	0	USD
CY2018Q1	gahr	Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests	67000	USD
CY2017	gahr	Advisory Agreement Term AdvisoryAgreementTerm	P1Y
CY2016Q1	gahr	Aggregate Maximum Amount Of Common Stock Issuable Under Public Offering AggregateMaximumAmountOfCommonStockIssuableUnderPublicOffering	3150000000	USD
CY2016Q2	gahr	Aggregate Reallocated Maximum Amountof Common Stock Issuable Under Primary Public Offering AggregateReallocatedMaximumAmountofCommonStockIssuableUnderPrimaryPublicOffering	3150000000	USD
CY2017Q1	gahr	Amortization Expense On Lease Commissions AmortizationExpenseOnLeaseCommissions	0	USD
CY2018Q1	gahr	Amortization Expense On Lease Commissions AmortizationExpenseOnLeaseCommissions	8000	USD
CY2017Q1	gahr	Amortizationof Identified Intangible Liabilities AmortizationofIdentifiedIntangibleLiabilities	68000	USD
CY2018Q1	gahr	Amortizationof Identified Intangible Liabilities AmortizationofIdentifiedIntangibleLiabilities	85000	USD
CY2017Q1	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	2000	USD
CY2018Q1	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	15000	USD
CY2018Q1	gahr	Ancillaryservicerevenue Ancillaryservicerevenue	186000	USD
CY2018Q1	gahr	Capitalized Acquisition Costsand Fees Additions CapitalizedAcquisitionCostsandFeesAdditions	695000	USD
	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	77746	shares
	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	118934	shares
CY2018Q1	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	41188	shares
	gahr	Condition Two Percentage Of Operating Expense Of Net Income ConditionTwoPercentageOfOperatingExpenseOfNetIncome	0.250
CY2017Q1	gahr	Dealer Manager Fees DealerManagerFees	733000	USD
CY2018Q1	gahr	Dealer Manager Fees DealerManagerFees	493000	USD
CY2018Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses After Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive	692000	USD
CY2018Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear	254000	USD
CY2018Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive	125000	USD
CY2018Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Four FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour	125000	USD
CY2018Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Three FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree	147000	USD
CY2018Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Two FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo	310000	USD
CY2017	gahr	Finite Lived Intangible Liabilities Useful Life FiniteLivedIntangibleLiabilitiesUsefulLife	P16Y8M12D
CY2018Q1	gahr	Finite Lived Intangible Liabilities Useful Life FiniteLivedIntangibleLiabilitiesUsefulLife	P17Y
CY2016Q3	gahr	Line Of Credit Facility Number Of Potential Extensions LineOfCreditFacilityNumberOfPotentialExtensions	1	Extension
CY2017Q4	gahr	Line Of Credit Facility Number Of Potential Extensions LineOfCreditFacilityNumberOfPotentialExtensions	1	Extension_period
CY2016Q3	gahr	Line Of Credit Facility Potential Extension Term LineOfCreditFacilityPotentialExtensionTerm	P12M
CY2017Q4	gahr	Line Of Credit Facility Potential Extension Term LineOfCreditFacilityPotentialExtensionTerm	P12M
CY2017Q4	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	82644000	USD
CY2018Q1	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	61062000	USD
CY2017Q4	gahr	Maximum Investment Rate By Officer Evp MaximumInvestmentRateByOfficerEVP	0.15
CY2016Q4	gahr	Maximum Investment Rate By Officer Evp MaximumInvestmentRateByOfficerEVP	0.150
	gahr	Maximum Percentage Of Common Stock Repurchased During Period MaximumPercentageOfCommonStockRepurchasedDuringPeriod	0.050
	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.060
CY2017Q1	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.060
CY2018Q1	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.06
CY2018Q1	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.060
	gahr	Maximumpercentageofdealermanagerfee Maximumpercentageofdealermanagerfee	0.030
CY2018Q1	gahr	Maximumpercentageofdealermanagerfee Maximumpercentageofdealermanagerfee	0.030
CY2017	gahr	Maximumpercentageofstockholderservicingfee Maximumpercentageofstockholderservicingfee	0.040
CY2017Q4	gahr	Minimum Investment Rate By Officer Evp MinimumInvestmentRateByOfficerEVP	0.05
CY2016Q4	gahr	Minimum Investment Rate By Officer Evp MinimumInvestmentRateByOfficerEVP	0.050
CY2018Q1	gahr	Minimum Percent Share Of Annualized Base Rent Accounted By Tenants MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants	0.100
CY2018Q1	gahr	Minimum Percent Share Of Each State Annualized Base Rent That Company Owned MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned	0.1
	gahr	Number Of Buildings Acquired From Unaffiliated Parties NumberOfBuildingsAcquiredFromUnaffiliatedParties	42	Building
CY2018Q1	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	2	MortgageLoan
CY2018Q1	gahr	Number Of Tenants With More Than Ten Percent Of Annual Base Rent NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent	2
	gahr	Numberof Acquisitions Completedfrom Unaffiliated Parties NumberofAcquisitionsCompletedfromUnaffiliatedParties	19	Acquisition
	gahr	Numberof Properties Acquiredfrom Unaffiliated Parties NumberofPropertiesAcquiredfromUnaffiliatedParties	40	Property
CY2017Q1	gahr	Other Amortization OtherAmortization	77000	USD
CY2018Q1	gahr	Other Amortization OtherAmortization	207000	USD
CY2018Q1	gahr	Ownership Percentage Properties OwnershipPercentageProperties	1.00
CY2017Q1	gahr	Payments For Proceeds From Security Deposits Financing Activities PaymentsForProceedsFromSecurityDepositsFinancingActivities	0	USD
CY2018Q1	gahr	Payments For Proceeds From Security Deposits Financing Activities PaymentsForProceedsFromSecurityDepositsFinancingActivities	-2000	USD
CY2017Q1	gahr	Paymentsfor Preacquisitionexpenses PaymentsforPreacquisitionexpenses	0	USD
CY2018Q1	gahr	Paymentsfor Preacquisitionexpenses PaymentsforPreacquisitionexpenses	42000	USD
	gahr	Percentage Of Dealer Manager Fee PercentageOfDealerManagerFee	0.010
	gahr	Percentage Of Dealer Manager Fee PercentageOfDealerManagerFee	0.010
CY2017Q1	gahr	Preacquisitionexpenses Incurredbut Notyet Paid PreacquisitionexpensesIncurredbutNotyetPaid	0	USD
CY2018Q1	gahr	Preacquisitionexpenses Incurredbut Notyet Paid PreacquisitionexpensesIncurredbutNotyetPaid	119000	USD
CY2017Q1	gahr	Receivable From Transfer Agent ReceivableFromTransferAgent	521000	USD
CY2018Q1	gahr	Receivable From Transfer Agent ReceivableFromTransferAgent	1158000	USD
CY2017Q1	gahr	Selling Commissions Expenses SellingCommissionsExpenses	2070000	USD
CY2018Q1	gahr	Selling Commissions Expenses SellingCommissionsExpenses	1462000	USD
	gahr	Selling Commissions Percentage SellingCommissionsPercentage	0.030
	gahr	Share Repurchase Plan Holding Period Condition One ShareRepurchasePlanHoldingPeriodConditionOne	P1Y
CY2018Q1	gahr	Share Repurchase Plan Percentageof Priceper Share Condition One ShareRepurchasePlanPercentageofPriceperShareConditionOne	0.925
CY2018Q1	gahr	Share Repurchase Plan Percentageof Priceper Share Condition Two ShareRepurchasePlanPercentageofPriceperShareConditionTwo	1.00
CY2017Q1	gahr	Sharesissuedindiscount Sharesissuedindiscount	3000	USD
CY2018Q1	gahr	Sharesissuedindiscount Sharesissuedindiscount	0	USD
	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.45
	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.52
CY2018Q1	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.65
	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	735000	USD
	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	1132000	USD
CY2018Q1	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	397000	USD
CY2017Q1	gahr	Stockholder Servicing Fee Incurred StockholderServicingFeeIncurred	2754000	USD
CY2018Q1	gahr	Stockholder Servicing Fee Incurred StockholderServicingFeeIncurred	1700000	USD
CY2017Q4	gahr	Stockholder Servicing Fee Payable StockholderServicingFeePayable	12611000	USD
CY2018Q1	gahr	Stockholder Servicing Fee Payable StockholderServicingFeePayable	13423000	USD
	gahr	Stockholderdailyservicingfeepercentage Stockholderdailyservicingfeepercentage	0.010
CY2017Q1	gahr	Tenant Improvement Overage TenantImprovementOverage	0	USD
CY2018Q1	gahr	Tenant Improvement Overage TenantImprovementOverage	429000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	19428000	USD
CY2018Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	21995000	USD
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2838000	USD
CY2018Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	4985000	USD
CY2017Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	554000	USD
CY2018Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	772000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	376284000	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	427228000	USD
CY2017Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4000	USD
CY2018Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3000	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	87000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	218000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	628000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3833000	USD
CY2018Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	2553000	sqft
CY2017Q1	us-gaap	Asset Management Fees1 AssetManagementFees1	301000	USD
CY2018Q1	us-gaap	Asset Management Fees1 AssetManagementFees1	958000	USD
CY2017Q4	us-gaap	Assets Assets	480153000	USD
CY2018Q1	us-gaap	Assets Assets	503642000	USD
CY2017Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	73000	USD
CY2018Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	95000	USD
CY2017Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	669000	USD
CY2018Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1285000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2237000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2059000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7087000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7087000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9158000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9158000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2237000	USD
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2059000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7103000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9174000	USD
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-178000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2071000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2017Q1	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	1187000	USD
CY2018Q1	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	2351000	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	3719000	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	18994000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11634000	USD
CY2018Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11538000	USD
CY2018Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11538000	USD
CY2017Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	326000	USD
CY2018Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	320000	USD
CY2018Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-740000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1456000	USD
CY2017Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	1912000	USD
CY2018Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	2546000	USD
CY2018Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-153000	USD
CY2017Q1	us-gaap	Depreciation Depreciation	1140000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	3416000	USD
CY2017Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1711000	USD
CY2018Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7195000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1711000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7195000	USD
CY2017Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	885000	USD
CY2018Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2398000	USD
CY2017Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	8118000	USD
CY2018Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	8146000	USD
CY2017Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8118000	USD
CY2018Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8146000	USD
CY2017Q4	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	500000	USD
CY2018Q1	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	2075000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2017	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P16Y2M12D
CY2018Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P16Y10M24D
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	18763000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	9663000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	3140000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3657000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4053000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4644000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43920000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	748000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2120000	USD
CY2017Q1	us-gaap	Health Care Organization Resident Service Revenue HealthCareOrganizationResidentServiceRevenue	0	USD
CY2018Q1	us-gaap	Health Care Organization Resident Service Revenue HealthCareOrganizationResidentServiceRevenue	8409000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	2000	USD
CY2018Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-50000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1807000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	429000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1378000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	37000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	18000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-165000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	291000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	422000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	98000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	44821000	USD
CY2018Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	43920000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	418000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	1084000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	356000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	879000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	125927000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	107271000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	480153000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	503642000	USD
CY2017	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest	0.9999
CY2018Q1	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest	0.9999
CY2017	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Members Or Limited Partners Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest	0.0001
CY2018Q1	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Members Or Limited Partners Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest	0.0001
CY2018Q1	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1653000	USD
CY2017Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	4052000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	100000000	USD
CY2017Q4	us-gaap	Line Of Credit LineOfCredit	84100000	USD
CY2017Q4	us-gaap	Line Of Credit LineOfCredit	84100000	USD
CY2018Q1	us-gaap	Line Of Credit LineOfCredit	62300000	USD
CY2018Q1	us-gaap	Line Of Credit LineOfCredit	62300000	USD
CY2016Q3	us-gaap	Line Of Credit Facility Collateral LineOfCreditFacilityCollateral	750000000
CY2017Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	84088000	USD
CY2018Q1	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	62294000	USD
CY2018Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	200000000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	200000000	USD
CY2017Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	11819000	USD
CY2018Q1	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	11628000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	2161000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	330000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	314000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	8036000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	407000	USD
CY2018Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	290000	USD
CY2017Q4	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.0001
CY2018Q1	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.0001
CY2017Q4	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.9999
CY2018Q1	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.9999
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	73985000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22873000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-75553000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25494000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1390000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4692000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-85000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-2169000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-67000	USD
CY2017Q1	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	103000	USD
CY2018Q1	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	8000	USD
CY2017Q1	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	360000	USD
CY2018Q1	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2017Q1	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	125000	USD
CY2018Q1	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	112000	USD
CY2018Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2018Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2018Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	3	State
CY2017Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1737000	USD
CY2017Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1737000	USD
CY2018Q1	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1653000	USD
CY2018Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	9433000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	5226000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	5226000	USD
CY2018Q1	us-gaap	Other Assets OtherAssets	5800000	USD
CY2018Q1	us-gaap	Operations Commenced Date1 OperationsCommencedDate1	2015-02-06
CY2018Q1	us-gaap	Other Assets OtherAssets	5800000	USD
CY2017Q4	us-gaap	Other Liabilities OtherLiabilities	977000	USD
CY2018Q1	us-gaap	Other Liabilities OtherLiabilities	1694000	USD
CY2017Q1	us-gaap	Owned Property Management Costs OwnedPropertyManagementCosts	0	USD
CY2018Q1	us-gaap	Owned Property Management Costs OwnedPropertyManagementCosts	7233000	USD
CY2017Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	2000	USD
CY2018Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	4000	USD
CY2017Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	39000	USD
CY2018Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	687000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	800000	USD
CY2018Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	1575000	USD
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	397000	USD
CY2017Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	755000	USD
CY2018Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2799000	USD
CY2017Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	14000	USD
CY2018Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2000	USD
CY2017Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3009000	USD
CY2018Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4125000	USD
CY2017Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	74714000	USD
CY2018Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	23190000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1532000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1696000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	76125000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	52094000	USD
	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	9485000	USD
	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	13091000	USD
CY2017Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	60000000	USD
CY2018Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	22600000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-85000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-2236000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	14000	USD
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	347000	USD
CY2017Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	8885000	USD
CY2018Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	12187000	USD
CY2017Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	419665000	USD
CY2017Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	428550000	USD
CY2018Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	449875000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	1002000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	1002000	USD
CY2018Q1	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	1002000	USD
CY2018Q1	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	1002000	USD
CY2017Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	4089000	USD
CY2018Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	2975000	USD
CY2017Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	58300000	USD
CY2017Q1	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	2000	USD
CY2017Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	419665000	USD
CY2018Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	437688000	USD
CY2018Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	437688000	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	2000	USD
CY2018Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	44400000	USD
CY2017Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	62000	USD
CY2017Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	62000	USD
CY2018Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	96000	USD
CY2016Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2017Q1	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	16000	USD
CY2018Q1	us-gaap	Restricted Cash RestrictedCash	16000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16000	USD
CY2018Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23482000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32337000	USD
CY2017Q1	us-gaap	Revenues Revenues	2865000	USD
CY2018Q1	us-gaap	Revenues Revenues	8258000	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	4052000	USD
CY2018Q1	us-gaap	Sales Revenue Net SalesRevenueNet	17842000	USD
CY2016Q4	us-gaap	Secured Debt SecuredDebt	3965000	USD
CY2017Q1	us-gaap	Secured Debt SecuredDebt	3901000	USD
CY2017Q4	us-gaap	Secured Debt SecuredDebt	11567000	USD
CY2018Q1	us-gaap	Secured Debt SecuredDebt	11483000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	14000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	30000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	37500	shares
CY2017Q1	us-gaap	Stock Issued1 StockIssued1	1063000	USD
CY2018Q1	us-gaap	Stock Issued1 StockIssued1	3606000	USD
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	1008075	shares
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	1391831	shares
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	1391831	shares
CY2017Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1063000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	3606000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	353224000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	395369000	USD
CY2017Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-273000	USD
CY2018Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-633000	USD
CY2018Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	893000	USD
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14655107	shares
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	45136647	shares
CY2018Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1. Organization and Description of Business</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:10px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Griffin-American Healthcare REIT IV, Inc., a Maryland corporation, was incorporated on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January 23, 2015</font><font style="font-family:inherit;font-size:10pt;"> and therefore we consider that our date of inception. We were initially capitalized on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">February 6, 2015</font><font style="font-family:inherit;font-size:10pt;">. We invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings, hospitals, skilled nursing facilities, senior housing and other healthcare-related facilities. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). We may also originate and acquire secured loans and real estate-related investments on an infrequent and opportunistic basis. We generally seek investments that produce current income. We qualified to be taxed as a real estate investment trust, or REIT, under the Code for federal income tax purposes beginning with our taxable year ended December 31, 2016, and we intend to continue to qualify to be taxed as a REIT.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 16, 2016, we commenced our initial public offering, or our offering, in which we were initially offering to the public up to </font><font style="font-family:inherit;font-size:10pt;">$3,150,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock, consisting of up to </font><font style="font-family:inherit;font-size:10pt;">$3,000,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock at a price of </font><font style="font-family:inherit;font-size:10pt;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share in our primary offering and up to </font><font style="font-family:inherit;font-size:10pt;">$150,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock for </font><font style="font-family:inherit;font-size:10pt;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share pursuant to our distribution reinvestment plan, as amended, or the DRIP. Effective June 17, 2016, we reallocated certain of the unsold shares of Class T common stock being offered and began offering shares of Class I common stock, such that we are currently offering up to approximately </font><font style="font-family:inherit;font-size:10pt;">$2,800,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of Class T common stock and </font><font style="font-family:inherit;font-size:10pt;">$200,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of Class I common stock in our primary offering, and up to an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$150,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T and Class I common stock pursuant to the DRIP, aggregating up to </font><font style="font-family:inherit;font-size:10pt;">$3,150,000,000</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The shares of our Class T common stock in our primary offering were being offered at a price of </font><font style="font-family:inherit;font-size:10pt;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share prior to April 11, 2018. The shares of our Class I common stock in our primary offering were being offered at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.30</font><font style="font-family:inherit;font-size:10pt;"> per share prior to March 1, 2017 and </font><font style="font-family:inherit;font-size:10pt;">$9.21</font><font style="font-family:inherit;font-size:10pt;"> per share from March 1, 2017 to April 10, 2018. The shares of our Class T and Class I common stock issued pursuant to the DRIP were sold at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share prior to January 1, 2017 and </font><font style="font-family:inherit;font-size:10pt;">$9.40</font><font style="font-family:inherit;font-size:10pt;"> per share from January 1, 2017 to April 10, 2018. On April 6, 2018, our board of directors, at the recommendation of the audit committee of our board of directors, comprised solely of independent directors, unanimously approved and established an estimated per share net asset value, or NAV, of our common stock of </font><font style="font-family:inherit;font-size:10pt;">$9.65</font><font style="font-family:inherit;font-size:10pt;">. As a result, on April 6, 2018, our board of directors unanimously approved revised offering prices for each class of shares of our common stock to be sold in the primary portion of our initial public offering based on the estimated per share NAV of our Class T and Class I common stock of </font><font style="font-family:inherit;font-size:10pt;">$9.65</font><font style="font-family:inherit;font-size:10pt;"> plus any applicable per share up-front selling commissions and dealer manager fees funded by us, effective April 11, 2018. Accordingly, the revised offering price for shares of our Class T common stock and Class I common stock sold pursuant to our primary offering on or after April 11, 2018 is </font><font style="font-family:inherit;font-size:10pt;">$10.05</font><font style="font-family:inherit;font-size:10pt;"> per share and </font><font style="font-family:inherit;font-size:10pt;">$9.65</font><font style="font-family:inherit;font-size:10pt;"> per share, respectively. Effective April 11, 2018, the shares of our Class T and Class I common stock issued pursuant to the DRIP are sold at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.65</font><font style="font-family:inherit;font-size:10pt;"> per share, the most recent estimated per share NAV approved and established by our board of directors.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We will sell shares of our Class T and Class I common stock in our offering until February 16, 2019, unless extended by our board of directors as permitted under applicable law, or extended with respect to shares of our common stock offered pursuant to the DRIP. We reserve the right to reallocate the shares of common stock we are offering between the primary offering and the DRIP, and among classes of stock. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we had received and accepted subscriptions in our offering for </font><font style="font-family:inherit;font-size:10pt;">46,532,759</font><font style="font-family:inherit;font-size:10pt;"> aggregate shares of our Class T and Class I common stock, or approximately </font><font style="font-family:inherit;font-size:10pt;">$462,971,000</font><font style="font-family:inherit;font-size:10pt;">, excluding shares of our common stock issued pursuant to the DRIP.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We conduct substantially all of our operations through Griffin-American Healthcare REIT IV Holdings, LP, or our operating partnership. We are externally advised by Griffin-American Healthcare REIT IV Advisor, LLC, or our advisor, pursuant to an advisory agreement, or the Advisory Agreement, between us and our advisor. The Advisory Agreement was effective as of February 16, 2016 and had a </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">-year term, subject to successive </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">-year renewals upon the mutual consent of the parties. The Advisory Agreement was last renewed pursuant to the mutual consent of the parties on February 14, 2018 and expires on February 16, 2019. Our advisor uses its best efforts, subject to the oversight and review of our board of directors, to, among other things, research, identify, review and make investments in and dispositions of properties and securities on our behalf consistent with our investment policies and objectives. Our advisor performs its duties and responsibilities under the Advisory Agreement as our fiduciary. Our advisor is </font><font style="font-family:inherit;font-size:10pt;">75.0%</font><font style="font-family:inherit;font-size:10pt;"> owned and managed by American Healthcare Investors, LLC, or American Healthcare Investors, and </font><font style="font-family:inherit;font-size:10pt;">25.0%</font><font style="font-family:inherit;font-size:10pt;"> owned by a wholly owned subsidiary of Griffin Capital Company, LLC, or Griffin Capital, or collectively, our co-sponsors. American Healthcare Investors is </font><font style="font-family:inherit;font-size:10pt;">47.1%</font><font style="font-family:inherit;font-size:10pt;"> owned by AHI Group Holdings, LLC, or AHI Group Holdings, </font><font style="font-family:inherit;font-size:10pt;">45.1%</font><font style="font-family:inherit;font-size:10pt;"> indirectly owned by Colony NorthStar, Inc. (NYSE: CLNS), or Colony NorthStar, and </font><font style="font-family:inherit;font-size:10pt;">7.8%</font><font style="font-family:inherit;font-size:10pt;"> owned by James F. Flaherty III, a former partner of Colony NorthStar. We are not affiliated with Griffin Capital, Griffin Capital Securities, LLC, or our dealer manager, Colony NorthStar or Mr. Flaherty; however, we are affiliated with Griffin-American Healthcare REIT IV Advisor, American Healthcare Investors and AHI Group Holdings.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We currently operate through </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> reportable business segments — medical office buildings, senior housing, senior housing — RIDEA and skilled nursing facilities. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we had completed </font><font style="font-family:inherit;font-size:10pt;">19</font><font style="font-family:inherit;font-size:10pt;"> property acquisitions whereby we owned </font><font style="font-family:inherit;font-size:10pt;">40</font><font style="font-family:inherit;font-size:10pt;"> properties, comprising </font><font style="font-family:inherit;font-size:10pt;">42</font><font style="font-family:inherit;font-size:10pt;"> buildings, or approximately </font><font style="font-family:inherit;font-size:10pt;">2,553,000</font><font style="font-family:inherit;font-size:10pt;"> square feet of gross leasable area, or GLA, for an aggregate contract purchase price of </font><font style="font-family:inherit;font-size:10pt;">$488,740,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
CY2018Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:10px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of our accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are made and evaluated on an on-going basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0001632970-18-000078-index-headers.html	Edgar Link	pending
0001632970-18-000078-index.html	Edgar Link	pending
0001632970-18-000078.txt	Edgar Link	pending
0001632970-18-000078-xbrl.zip	Edgar Link	pending
ex311-gahr4x10xq2018xq1.htm	Edgar Link	pending
ex312-gahr4x10xq2018xq1.htm	Edgar Link	pending
ex321-gahr4x10xq2018xq1.htm	Edgar Link	pending
ex322-gahr4x10xq2018xq1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gahr-20180331.xml	Edgar Link	completed
gahr-20180331.xsd	Edgar Link	pending
gahr-20180331_cal.xml	Edgar Link	unprocessable
gahr-20180331_def.xml	Edgar Link	unprocessable
gahr-20180331_lab.xml	Edgar Link	unprocessable
gahr-20180331_pre.xml	Edgar Link	unprocessable
gahr4-10xq2018xq1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHR
American Healthcare REIT, Inc. Stock $ahr

2018 Q1 Form 10-Q Financial Statement

#000163297018000078 Filed on May 11, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR American Healthcare REIT, Inc. Stock $ahr

2018 Q1 Form 10-Q Financial Statement

#000163297018000078 Filed on May 11, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR
American Healthcare REIT, Inc. Stock $ahr